BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2006
View Archived Issues
CKD-501 well tolerated in healthy subjects
Read More
Dopamine receptor occupancy of YKP-1358 determined
Read More
Potential antitumor activity of SIRT1 inhibitors / News in Context
Read More
Neurocrine Biosciences updates progress across pipeline
Read More
Neuromed supports calcium channel blocker programs with Series D financing
Read More
AC Immune identifies lead compounds for Alzheimer's disease
Read More
Epix completes enrollment in phase IIb study of EP-2104R
Read More
Allergan receives FTC approval for Inamed acquisition
Read More
VX-702 produces dose-dependent increase in ACR20 response rates
Read More
ALGRX-4975 meets primary endpoint of decreased pain for tendonitis patients
Read More
Active RA patients achieve ACR20 following HuMax-CD20 treatment
Read More
Snapshots of new dental research
Read More
Dimethylcurcumin claimed as a potential topical agent for acne vulgaris
Read More
Ad-IU-1 shows good profile as gene therapy for prostate cancer
Read More
Acadia presents new nonpeptidergic UII receptor agonists
Read More
XMRV: A novel virus behind prostate cancer?
Read More
Anticancer efficacy of satraplatin in vitro, in vivo and in patients with advanced solid tumors
Read More
Nikken Chemical obtains manufacturing and marketing rights for Selenica tablet
Read More
CV Therapeutics begins shipments of Ranexa
Read More
IND clearance for pharmacokinetic study of Nebido
Read More
New phase II study for SP-01A in treatment experienced HIV-infected patients
Read More
NICE recommends PDT to treat common skin cancer and premalignant lesions
Read More
LA-419 effective in a human model of thrombosis
Read More
GPR119 agonist identified and found to reduce food intake in a rat model of obesity
Read More
Kowa acquires the remaining common shares of Nikken Chemicals, bringing its ownership to 100%
Read More
StemCells receives IRB approval for phase I Batten disease study of HuCNS-SC
Read More
Kamada cleared to begin phase III trials of alpha1-proteinase inhibitor
Read More
Braintree inlicenses rights to chemoprevention agent BLI-600
Read More
Amgen updates AMG-714 progress
Read More
New antiglaucoma agents disclosed in recent patents
Read More
Anti-HCV drugs prepared and tested at Bristol-Myers Squibb
Read More
New patents describe therapeutic agents for asthma, COPD, emphysema, etc.
Read More